Cargando…

New structural forms of a mycobacterial adenylyl cyclase Rv1625c

Rv1625c is one of 16 adenylyl cyclases encoded in the genome of Mycobacterium tuberculosis. In solution Rv1625c exists predominantly as a monomer, with a small amount of dimer. It has been shown previously that the monomer is active and the dimeric fraction is inactive. Both fractions of wild-type R...

Descripción completa

Detalles Bibliográficos
Autores principales: Barathy, Deivanayaga, Mattoo, Rohini, Visweswariah, Sandhya, Suguna, Kaza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Union of Crystallography 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4174876/
https://www.ncbi.nlm.nih.gov/pubmed/25295175
http://dx.doi.org/10.1107/S2052252514016741
_version_ 1782336417827913728
author Barathy, Deivanayaga
Mattoo, Rohini
Visweswariah, Sandhya
Suguna, Kaza
author_facet Barathy, Deivanayaga
Mattoo, Rohini
Visweswariah, Sandhya
Suguna, Kaza
author_sort Barathy, Deivanayaga
collection PubMed
description Rv1625c is one of 16 adenylyl cyclases encoded in the genome of Mycobacterium tuberculosis. In solution Rv1625c exists predominantly as a monomer, with a small amount of dimer. It has been shown previously that the monomer is active and the dimeric fraction is inactive. Both fractions of wild-type Rv1625c crystallized as head-to-head inactive domain-swapped dimers as opposed to the head-to-tail dimer seen in other functional adenylyl cyclases. About half of the molecule is involved in extensive domain swapping. The strain created by a serine residue located on a hinge loop and the crystallization condition might have led to this unusual domain swapping. The inactivity of the dimeric form of Rv1625c could be explained by the absence of the required catalytic site in the swapped dimer. A single mutant of the enzyme was also generated by changing a phenylalanine predicted to occur at the functional dimer interface to an arginine. This single mutant exists as a dimer in solution but crystallized as a monomer. Analysis of the structure showed that a salt bridge formed between a glutamate residue in the N-terminal segment and the mutated arginine residue hinders dimer formation by pulling the N-terminal region towards the dimer interface. Both structures reported here show a change in the dimerization-arm region which is involved in formation of the functional dimer. It is concluded that the dimerization arm along with other structural elements such as the N-terminal region and certain loops are vital for determining the oligomeric nature of the enzyme, which in turn dictates its activity.
format Online
Article
Text
id pubmed-4174876
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher International Union of Crystallography
record_format MEDLINE/PubMed
spelling pubmed-41748762014-10-07 New structural forms of a mycobacterial adenylyl cyclase Rv1625c Barathy, Deivanayaga Mattoo, Rohini Visweswariah, Sandhya Suguna, Kaza IUCrJ Research Papers Rv1625c is one of 16 adenylyl cyclases encoded in the genome of Mycobacterium tuberculosis. In solution Rv1625c exists predominantly as a monomer, with a small amount of dimer. It has been shown previously that the monomer is active and the dimeric fraction is inactive. Both fractions of wild-type Rv1625c crystallized as head-to-head inactive domain-swapped dimers as opposed to the head-to-tail dimer seen in other functional adenylyl cyclases. About half of the molecule is involved in extensive domain swapping. The strain created by a serine residue located on a hinge loop and the crystallization condition might have led to this unusual domain swapping. The inactivity of the dimeric form of Rv1625c could be explained by the absence of the required catalytic site in the swapped dimer. A single mutant of the enzyme was also generated by changing a phenylalanine predicted to occur at the functional dimer interface to an arginine. This single mutant exists as a dimer in solution but crystallized as a monomer. Analysis of the structure showed that a salt bridge formed between a glutamate residue in the N-terminal segment and the mutated arginine residue hinders dimer formation by pulling the N-terminal region towards the dimer interface. Both structures reported here show a change in the dimerization-arm region which is involved in formation of the functional dimer. It is concluded that the dimerization arm along with other structural elements such as the N-terminal region and certain loops are vital for determining the oligomeric nature of the enzyme, which in turn dictates its activity. International Union of Crystallography 2014-08-22 /pmc/articles/PMC4174876/ /pubmed/25295175 http://dx.doi.org/10.1107/S2052252514016741 Text en © Deivanayaga Barathy et al. 2014 http://creativecommons.org/licenses/by/2.0/uk/ This is an open-access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.
spellingShingle Research Papers
Barathy, Deivanayaga
Mattoo, Rohini
Visweswariah, Sandhya
Suguna, Kaza
New structural forms of a mycobacterial adenylyl cyclase Rv1625c
title New structural forms of a mycobacterial adenylyl cyclase Rv1625c
title_full New structural forms of a mycobacterial adenylyl cyclase Rv1625c
title_fullStr New structural forms of a mycobacterial adenylyl cyclase Rv1625c
title_full_unstemmed New structural forms of a mycobacterial adenylyl cyclase Rv1625c
title_short New structural forms of a mycobacterial adenylyl cyclase Rv1625c
title_sort new structural forms of a mycobacterial adenylyl cyclase rv1625c
topic Research Papers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4174876/
https://www.ncbi.nlm.nih.gov/pubmed/25295175
http://dx.doi.org/10.1107/S2052252514016741
work_keys_str_mv AT barathydeivanayaga newstructuralformsofamycobacterialadenylylcyclaserv1625c
AT mattoorohini newstructuralformsofamycobacterialadenylylcyclaserv1625c
AT visweswariahsandhya newstructuralformsofamycobacterialadenylylcyclaserv1625c
AT sugunakaza newstructuralformsofamycobacterialadenylylcyclaserv1625c